AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
AbbVie (NYSE: ABBV) has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference scheduled for Tuesday, September 9, 2025. The company's management will engage in a fireside chat presentation at 9:00 a.m. Central time.
Investors can access the presentation through a live audio webcast on AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the session will be made available later the same day.
AbbVie (NYSE: ABBV) parteciperà al Morgan Stanley 23rd Annual Global Healthcare Conference previsto per martedì 9 settembre 2025. La direzione terrà una presentazione in formato fireside chat alle 9:00 (Central Time).
Gli investitori potranno seguire la presentazione in diretta audio tramite webcast sul sito Investor Relations di AbbVie all'indirizzo investors.abbvie.com. Una registrazione sarà disponibile in archivio più tardi nella stessa giornata.
AbbVie (NYSE: ABBV) participará en el Morgan Stanley 23rd Annual Global Healthcare Conference programado para el martes 9 de septiembre de 2025. La dirección ofrecerá una presentación en formato fireside chat a las 9:00 a.m. hora Central.
Los inversores podrán acceder a la presentación mediante una retransmisión de audio en directo en el sitio de Relaciones con Inversores de AbbVie en investors.abbvie.com. Más tarde ese mismo día se publicará una versión archivada de la sesión.
AbbVie (NYSE: ABBV)는 2025년 9월 9일 화요일에 예정된 Morgan Stanley 23rd Annual Global Healthcare Conference에 참가합니다. 경영진은 중부 표준시(Central) 오전 9:00에 파이어사이드 채트(fireside chat) 형식의 발표를 진행합니다.
투자자들은 AbbVie 투자자 관계 웹사이트 investors.abbvie.com에서 오디오 라이브 웹캐스트로 발표를 시청할 수 있습니다. 같은 날 늦게 세션의 녹화본이 아카이브로 제공됩니다.
AbbVie (NYSE: ABBV) participera à la Morgan Stanley 23rd Annual Global Healthcare Conference prévue le mardi 9 septembre 2025. La direction tiendra une présentation en format fireside chat à 9h00, heure centrale (Central Time).
Les investisseurs pourront suivre la présentation en direct audio via un webcast sur le site Relations Investisseurs d'AbbVie à l'adresse investors.abbvie.com. Une version archivée de la session sera mise en ligne plus tard dans la journée.
AbbVie (NYSE: ABBV) wird an der Morgan Stanley 23rd Annual Global Healthcare Conference teilnehmen, die für Dienstag, den 9. September 2025 angesetzt ist. Das Management wird um 9:00 Uhr Central Time in einer Fireside-Chat-Präsentation auftreten.
Anleger können die Präsentation per Live-Audio-Webcast auf der Investor-Relations-Seite von AbbVie unter investors.abbvie.com verfolgen. Eine Aufzeichnung wird später am selben Tag als Archiv verfügbar sein.
- None.
- None.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: Gabby Tarbert | Investors: Liz Shea |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference-302542190.html
SOURCE AbbVie
FAQ
When is AbbVie (ABBV) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors watch AbbVie's Morgan Stanley conference presentation?
Will AbbVie's Morgan Stanley conference presentation be available after the event?
What type of presentation will AbbVie give at the Morgan Stanley Healthcare Conference?
